Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Motif lengths of circular codes in coding sequences.

Journal of theoretical biology·2021

Same author

[Therapeutic alternatives to surgical treatment of malignant eyelid tumors and their precursors].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020

Same author

[Treatment reality with ranibizumab in clinical routine use for patients with diabetic macular edema : 1‑year results of the German POLARIS cohort].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018

Same author

[Retinal manifestation in hematological diseases].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018

Same author

[Misdiagnosis due to incomplete medical history].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018

Same author

[Diagnostic Approaches to Suspected Choroidal Melanoma].

Klinische Monatsblatter fur Augenheilkunde·2017

Search research articles

Related Experiment Video

Updated: Mar 17, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

[Proliferative Vitreoretinopathy].

P Wiedemann¹, A Bringmann¹

¹Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Leipzig.

Klinische Monatsblatter Fur Augenheilkunde

|August 2, 2016

Summary

This summary is machine-generated.

Proliferative vitreoretinal retinopathy (PVR) is a severe surgical complication. Surgical removal of cellular membranes and the vitreous body is the primary treatment goal for PVR.

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

Related Experiment Videos

Last Updated: Mar 17, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

Area of Science:

Ophthalmology
Retinal Surgery
Cellular Biology

Background:

Proliferative vitreoretinal retinopathy (PVR) is a severe complication following vitreoretinal surgery.
PVR involves a complex cellular reaction, mimicking a vitreoretinal wound healing process.
This reaction can lead to fixed tractional retinal detachment due to membrane formation.

Purpose of the Study:

To highlight the challenges and surgical necessity in managing proliferative vitreoretinal retinopathy.
To underscore the cellular mechanisms underlying PVR development post-surgery.

Main Methods:

Surgical intervention is the primary method discussed for addressing PVR.
The focus is on the removal of active cells and membranes.
Complete vitreous body excision is emphasized as a key surgical objective.

Main Results:

Surgical removal of membranes and vitreous is essential for PVR management.
The complex cellular response in PVR necessitates aggressive surgical intervention.
Effective treatment relies on surgically addressing the cellular proliferation and membrane formation.

Conclusions:

Surgical management is critical for treating proliferative vitreoretinal retinopathy.
Complete removal of the vitreous and membranes is the goal of PVR surgery.
Understanding the cellular reaction is key to effective surgical strategies for PVR.